This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,258.24, is a delivery order for the supply of Copaxone 40 mg/mL syringes, a specialty medication. The contract has a firm-fixed price pricing type and an ultimate completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $181,775.17, is for the delivery of Copaxone 20mg 1mL 30s, a multiple sclerosis medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 19, 2015. This award is not designated as a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Copaxone 20 mg/mL syringes to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,083.79 firm fixed-price delivery order has a completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a Firm Fixed Price Delivery Order for the supply of COPAXONE 40 MG/ML syringes. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML syringes, a medication used to treat multiple sclerosis. The contract has a firm fixed price of $3,486.00 and a period of performance through October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,455.71 firm-fixed-price delivery order is for COPAXONE 20 MG/ML SYRINGEML, a medication, with a period of performance through July 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is for the supply of 4566719549 units of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB25FKXZ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.47 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication, with a completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,215.36, is for the supply of COPAXONE 40 MG/ML syringes, a specialty medication used to treat multiple sclerosis. The contract has a fixed-price delivery order structure and an ultimate completion date of August 26, 2024. AmerisourceBergen holds a larger $999,999,999...